Study suggests aspirin may reduce risk of melanoma
A new Stanford University study suggests taking aspirin may reduce the risk of melanoma in women.
Researchers looked at nearly 60,000 postmenopausal women for 12 years in the largest study of its kind. They found the women who took regular doses of aspirin lowered their risk of getting melanoma by at least 20 percent.
Researchers believe inflammation plays a big role in cancer development and aspirin is an anti-inflammatory drug. But they caution that an aspirin a day won't keep melanoma away.
The study can be found in the journal Cancer.
stanford university, cancer, medical research, health
- Family: Children's Hospital calls girl 'dead'
- BART Board president wants to ban transit strikes
- Dozens hurt after London theater partially collapsed
- 'Duck Dynasty' fans react to Robertson's hiatus
- San Jose charity 3,000 short of toy distribution goal 41 min ago
- Last minute Christmas shopping is in full swing
- 'Wonder Girl' cancer patient is inspiration for Vallejo
- Report says bullying of American-Islamic kids on rise
- 1 dead, dozens hurt in California bus crashes
- Only On 7: Sneak peek at the SF Zoo's baby gorilla
- abcnews: Dennis Rodman does karaoke in NKorea
- Bay Area New Year's Eve fireworks and events
- roundup: CPUC fines PG&E; Homeless memorial 5 min ago
- weather: Bay Area weather forecast for Friday
Most Viewed StoriesMost Viewed Photos